Status:

ACTIVE_NOT_RECRUITING

Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

Lead Sponsor:

Menzies School of Health Research

Collaborating Sponsors:

Papua New Guinea Institute of Medical Research

University of Melbourne

Conditions:

Malaria

Malaria in Pregnancy

Eligibility:

FEMALE

16+ years

Phase:

PHASE3

Brief Summary

This trial tests the hypothesis that intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) plus dihydroartemisinin-piperaquine (DP) significantly reduces the risk o...

Detailed Description

Plasmodium falciparum and P. vivax infections cause malaria, maternal anemia and interfere with the development of the fetus, thereby increasing the risks of adverse pregnancy outcomes such as miscarr...

Eligibility Criteria

Inclusion

  • Pregnant women between 12-26 weeks' gestation
  • 16 years of age or older
  • Viable singleton intrauterine pregnancy
  • Permanent resident of the study area
  • Willing to adhere to scheduled and unscheduled study visit procedures
  • Willing to birth in a study clinic or hospital
  • Able to provide written informed consent

Exclusion

  • Multiple pregnancy (i.e. twins/triplets)
  • Known heart ailment or other chronic medical condition requiring frequent hospital care
  • Active medical problem requiring inpatient evaluation at the time of screening
  • Severe malformations or non-viable pregnancy if observed by ultrasound
  • Antimalarial therapy in the prior two weeks
  • Unable to provide written informed consent
  • Known allergy or contraindication to any of the study drugs
  • Early or active labour
  • Known HIV-positive status

Key Trial Info

Start Date :

August 31 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

1172 Patients enrolled

Trial Details

Trial ID

NCT05426434

Start Date

August 31 2022

End Date

December 1 2025

Last Update

June 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Papua New Guinea Institute of Medical Research

Madang, Madang Province, Papua New Guinea, 511

Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy | DecenTrialz